RetractedArticleMolecular cancer therapeutics2015

Aromatase Inhibitor-Mediated Downregulation of INrf2 (Keap1) Leads to Increased Nrf2 and Resistance in Breast Cancer.

Raju Khatri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.